SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001818382-22-000113
Filing Date
2022-09-01
Accepted
2022-09-01 16:09:06
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 humaresales-3.htm S-3 605888
2 EX-FILING FEES humaresales-3xexhibit107.htm EX-FILING FEES 22386
3 EX-5.1 humaresales-3xexhibit51.htm EX-5.1 12111
4 EX-23.2 humaresales-3exhibit232.htm EX-23.2 3021
5 covingtonheader2.jpg GRAPHIC 11514
6 covingtonletterhead.jpg GRAPHIC 50786
7 humacyte.jpg GRAPHIC 15450
  Complete submission text file 0001818382-22-000113.txt   741130
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267222 | Film No.: 221221054
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences